Skip to main content
Mobile dropdown close
More coming soon
Industry Report: Explore these additional resources
1 - 10 of 30 Displaying Results
Solving the COVID-19 Pharma Supply Chain Struggle
See exclusive research on COVID-19's impact on pharmaceutical supply chain agility, visibility, and resilience. Get actionable insights.
2016 Global Drug Supply, Safety and Traceability Report
See how 331 life sciences companies are faring with DSCSA lot-level requirements and serialization readiness.
Serialized Operations: Challenges and Opportunities
How do your serialized operations compare with more 100+ pharmaceutical companies? Get the results of TraceLink's serialization program assessment.
Top 30 Insights from Pfizer, Sagent, Patheon & McKesson
Continued insights from the speakers at our DSCSA Serialization Workshop: Pfizer, Sagent, Patheon and McKesson.
Premier Chooses TraceLink to Offer DSCSA Compliance Solutions to 130,000 Hospital Members
TraceLink announces a national group purchasing agreement with Premier Inc., a leading healthcare improvement company.
Ropack Selects TraceLink to Achieve DSCSA Compliance for its Pharmaceutical Customers
Ropack Pharma Solutions selects TraceLink to provide serialization solutions for its customers.
TraceLink Hosts OPEN-SCS Working Group at its U.S. Headquarters
TraceLink hosts a successful meeting for the Open Serialization Communication Standard (OPEN-SCS) Working Group.
Poll: 4 of 5 Phase 3s Are Preparing for Serialization Before FDA Approval
Polls show that 82% of clinical-stage virtual pharma companies, uncertain about the impact of serialization, are preparing for DSCSA compliance now.
Poll: Healthcare Organizations Unanimously Name Recall Management as Top Benefit of Serialization
Learn what else hospitals and pharmacies think about the upcoming wave of serialization requirements and benefits.
Poll: Validation Has Huge Time and Cost Impact
Find out how many internal resources companies are dedicating to, and how much they're spending on track and trace system validation.